Skip to main content
Renascience Inc. logo

Renascience Inc. — Investor Relations & Filings

Ticker · 4889 ISIN · JP3981100005 T Manufacturing
Open in API
Filings indexed 49 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country JP Japan
Listing T 4889

About Renascience Inc.

https://www.renascience.co.jp/en/

Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on the research and development of various medical modalities, including pharmaceuticals, medical devices, and artificial intelligence (AI) applications. A primary area of its R&D is the study of cellular senescence at the molecular level to develop novel medicines for diseases associated with tissue aging. While initially founded with a focus on kidney disease, Renascience collaborates with academic institutions and corporate partners to advance its diverse R&D pipelines through clinical trials.

Recent filings

Filing Released Lang Actions
局所進行非小細胞肺がんに対する第二相試験開始のお知らせ
Regulatory Filings
2026-04-24 Japanese
発行登録追補書類（株券､社債券等）
Capital/Financing Update Classification · 100% confidence The document is a 'Supplement to the Shelf Registration Statement' (発行登録追補書類) filed with the Tohoku Local Finance Bureau. It details the issuance of new stock acquisition rights (新株予約権証券) by Renascience Inc. to a specific investor (CVI Investments, Inc.) under an existing Equity Program Agreement. It includes specific terms of the issuance, use of proceeds, and legal disclosures required for securities offerings. This falls under the category of capital and financing updates.
2026-03-11 Japanese
発行登録追補書類（株券､社債券等）
Share Issue/Capital Change Classification · 95% confidence The document is a '発行登録追補書類' (Shelf Registration Supplement) filed with the Tohoku Local Finance Bureau by Renascience Inc. It details the issuance of new shares (third-party allotment) to CVI Investments, Inc. as part of an 'Equity Program Agreement'. This document provides specific terms of the share issuance, use of proceeds, and details regarding the counterparty. It is a formal regulatory filing related to capital raising and share issuance, which falls under the 'Share Issue/Capital Change' category.
2026-03-11 Japanese
発行登録追補書類（株券､社債券等）
Share Issue/Capital Change Classification · 100% confidence The document is a 'Registration Statement Supplement' (発行登録追補書類) filed with the Tohoku Local Finance Bureau by Renascience Inc. It details the issuance of new stock acquisition rights (新株予約権証券) to a third party (CVI Investments, Inc.) under an existing Equity Program Agreement. This document is a formal regulatory filing related to capital raising and share issuance, which falls under the 'Share Issue/Capital Change' category.
2026-02-18 Japanese
発行登録追補書類（株券､社債券等）
Capital/Financing Update Classification · 98% confidence The document is a 'Supplement to the Shelf Registration Statement' (発行登録追補書類) filed with the Tohoku Local Finance Bureau. It details a specific issuance of new shares (third-party allotment) to CVI Investments, Inc. as part of an 'Equity Program Agreement'. It includes specific terms of the offering, use of proceeds, and details about the allottee. This is a formal regulatory filing related to capital raising activities, which falls under the 'Capital/Financing Update' category.
2026-02-18 Japanese
発行登録追補書類（株券､社債券等）
Share Issue/Capital Change Classification · 95% confidence The document is a 'Registration Statement Supplement' (発行登録追補書類) filed with the Tohoku Local Finance Bureau by Renascience Inc. It details the issuance of new stock acquisition rights (新株予約権証券) to a third party (CVI Investments, Inc.) under an Equity Program Agreement. This type of filing is a regulatory document related to capital raising and share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-12-19 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.